NovoCure NVCR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableTradeCurrent.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's accounts payable?
- NovoCure (NVCR) reported accounts payable of $127.24M in Q1 2026.
- How has NovoCure's accounts payable changed year-over-year?
- NovoCure's accounts payable increased by 33.8% year-over-year, from $95.09M to $127.24M.
- What is the long-term trend for NovoCure's accounts payable?
- Over 5 years (2020 to 2025), NovoCure's accounts payable has grown at a 17.9% compound annual growth rate (CAGR), from $53.65M to $122.23M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.